Over $2.5 million to Rémi Rabasa-Lhoret for research on the artificial pancreas.

Dr Rémi Rabasa-Lhoret research team at IRCM is receiving a grant of more than $2.5M USD from the U.S. NIH for a clinical study on external artificial pancreas. The goal of the project is to compare glucose control achieved using the single-hormone (insulin only) artificial pancreas, the dual-hormone (insulin and glucagon) artificial pancreas, and the conventional insulin pump to deliver insulin.

Dr Rabasa-Lhoret team is leading the field of artificial pancreas development in Canada, a technology which has the potential to greatly reduce complication risks associated to a poor glucose control in people with type 1 diabetes. Click here for the IRCM news release.